Share

Monitoring of myelodysplastic syndromes (MDS)

Retrospective study for MDS monitoring in adult patients

Project Objectives

Primary objectives:

  • Evaluation of clinical and biological diagnosis for patients with MDS
  • Evaluation of the disease’s clinical course
  • Overall survival

Secondary objectives:

  • Evaluation of chemotherapy or adjuvant therapy in the various institutions involved and correlation with the diagnostic strategy employed
  • Evaluation of the type of treatment and therapeutic response related to the different subtypes, according to WHO and/or IPSS classification systems

Start/End Date

March 25, 2010 - ongoing

Principal Investigators

  • Prof. Giuseppe Avvisati
  • Dr. Carolina Nobile

Host Institution

Ospedale San Giovanni Addolorata, UOC Hematology - Rome

Other Institutions involved

  • Azienda Policlinico Umberto I, Sapienza Università di Roma, Department of Cellular Biotechnology and Hematology
  • Policlinico Universitario Tor Vergata (PTV, Hematology Unit.
  • Ospedale Nuova Regina Margherita, Division of Hematology
  • Azienda Ospedaliera San Giovanni Addolorata, Hematology Complex Operative Unit
  • Campus Bio-Medico University of Rome, Department of Hematology
  • Ospedale Sandro Pertini, Hematology Complex Operative Unit
  • Sapienza Università di Roma, Polo Pontino, Division of Hematology - Latina, Italy
  • Ospedale S. Eugenio, Division of Hematology - Rome, Italy
  • Università Cattolica Sacro Cuore, Division of Hematology, Institute of Hematology, Policlinico Agostino Gemelli - Rome, Italy
  • Azienda Ospedaliera San Camillo Forlanini, Department of Hematology - Italy
  • Azienda Ospedaliera Sant’Andrea - Sapienza Università di Roma, Second Faculty of Medicine, Department of Hematology 
  • Istituto Nazionale Tumori Regina Elena - italy
magnifiercrossmenuchevron-downchevron-leftchevron-right